Search details
1.
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
J Pathol
; 250(5): 667-684, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32129476
2.
Molecular profiling in muscle-invasive bladder cancer: more than the sum of its parts.
J Pathol
; 247(5): 563-573, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30604486
3.
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial.
Mod Pathol
; 30(8): 1069-1077, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28548129
4.
Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
Mod Pathol
; 30(4): 509-518, 2017 04.
Article
in English
| MEDLINE | ID: mdl-28084333
5.
Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients.
J Pathol Clin Res
; 4(4): 262-273, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30066480
6.
Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series.
J Pathol Clin Res
; 2(1): 32-40, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-27499914
Results
1 -
6
de 6
1
Next >
>>